rBIO, an early-stage synthetic biology company focused on reducing the cost of prescription drugs, has announced its first in-lab milestone: synthetic production of ... Dec 17
This partnership also signifies Lesaffre's entry into the world of Synthetic Biology, considered to be the major biotechnological opportunity of this decade... Oct 31
Synthetic Biology start up NanoSyrinx secures capital to develop its fully customisable platform for intra-cellular engineering ... Sep 30
-Advertisements-